Back to Search
Start Over
2023 Drug Pipeline.
- Source :
- Dermatology Times; Jan2023, Vol. 44 Issue 1, p48-49, 2p
- Publication Year :
- 2023
-
Abstract
- In the article, the author discusses the possible drugs that could be approved for dermatologic therapy and pharmacology in 2023. Also cited are the various skin pathologies like infectious, neoplastic, and autoimmune, their treatments like monoclonal antibodies, steroids, and chemotherapeutic agents, and some dermatology drugs for approval like Pfizer's ritlecitinib for treating alopecia areata (AA).
Details
- Language :
- English
- ISSN :
- 01966197
- Volume :
- 44
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Dermatology Times
- Publication Type :
- Periodical
- Accession number :
- 161220359